Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Unknown 3Completed 3Terminated 1

Sponsor Class

NIH 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Breast Neoplasms 37Central Nervous System Neoplasms 23Colorectal Neoplasms 20Glioblastoma 18Gliosarcoma 17Colonic Neoplasms 16Rectal Neoplasms 15Head and Neck Neoplasms 12Sarcoma 10Ovarian Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Pancreatic Neoplasms 9Esophageal Neoplasms 9Carcinoma, Intraductal, Noninfiltrating 9Brain Neoplasms 9Stomach Neoplasms 8Prostatic Neoplasms 8Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Breast Carcinoma In Situ 7Astrocytoma 7Adenocarcinoma Of Esophagus 7Salivary Gland Neoplasms 6Glioma 6Carcinoma, Ovarian Epithelial 6Breast Neoplasms, Male 6Neoplasm Metastasis 5Fallopian Tube Neoplasms 5Esophageal Squamous Cell Carcinoma 5Endometrial Neoplasms 5

Interventions

Sunitinib 86Sorafenib 60Everolimus 47pazopanib 46Bevacizumab 46Nivolumab 44pembrolizumab 37aldesleukin 29Interferon-alpha 26Axitinib 24temsirolimus 23cabozantinib 20Interleukin-2 19Ipilimumab 16Interferon alpha-2 15Cyclophosphamide 15fludarabine phosphate 14Gemcitabine 14Peripheral Blood Stem Cell Transplantation 11Sirolimus 10Paclitaxel 10Erlotinib Hydrochloride 10avelumab 8Radiosurgery 8Docetaxel 8Cyclosporine 8Capecitabine 8tremelimumab 7lenvatinib 7Mycophenolic Acid 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Carcinoma, Renal Cell × Chemotherapy, Adjuvant × Clear all
NCT00492258 2013-08-12

Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer

National Cancer Institute (NCI)

Phase 3 Completed
1,656 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01024205 2013-08-12

Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer

National Cancer Institute (NCI)

Phase 2 Completed
43 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00053807 2012-09-24

Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
96 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡